Bowel obstruction

Carla Ripamonti

doi:10.1017/CBO9780511527081.060

Baines, M, Oliver, D J, Carter, R L. Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study. Lancet 1985;Nov 2:990–3CrossRef Google Scholar PubMed

Cozzaglio, L, Balzola, F, Cosentino, F. Outcome of cancer patients receiving home parenteral nutrition. J Parenteral Enteral Nutrition 1997;21:339–42CrossRef Google Scholar PubMed

Davis, M P, Furste, A. Glycopyrrolate: a useful drug in the palliation of mechanical bowel obstruction. J Pain Symptom Manage 1999;18:153–4Google Scholar PubMed

Conno, F, Caraceni, A, Zecca, E, Spoldi, E, Ventafridda, V. Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Symptom Manage 1991;6/8:484–6CrossRef Google Scholar

Fainsinger, R L, MacEachern, T, Miller, M J. The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage 1994;9:298–302CrossRef Google Scholar PubMed

Fainsinger, R L, Spachynski, K, Hanson, J, Bruera, E. Symptom control in terminally ill patients with malignant bowel obstruction (MBO). J Pain Symptom Manage 1994;9/1:12–18CrossRef Google Scholar

Mercadante, S, Ripamonti, C, Casuccio, A, Zecca, E, Groff, L. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 2000;8:188–91CrossRef Google Scholar PubMed

Ripamonti, C, Mercadante, S, Groff, L, Zecca, E, Conno, F, Casuccio, A. Role of octreotide and scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage 2000;19:23–34CrossRef Google Scholar PubMed

Ventafridda, V, Ripamonti, C, Caraceni, A, Spoldi, E, Messina, L, Conno, F. The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 1990;76:389–93CrossRef Google Scholar PubMed

Wallis, F, Campbell, K L, Eremin, O, Hussey, J K. Self-expanding metal stents in the management of colorectal carcinoma – a preliminary report (see comments). Clin Radiol 1998;53:251–4CrossRef Google Scholar

Baines M J. Nausea, vomiting and intestinal obstruction. In ABC of Palliative Care, ed. M Fallon, B O'Neill, pp. 16–18. London: BMJ Books, 1998

Baines M J. The pathophysiology and management of malignant intestinal obstruction. In Oxford Textbook of Palliative Medicine, ed. D Doyle, G W C Hanks, N MacDonald, pp. 526–34. Oxford: Oxford University Press, 1998

Bozzetti, F, Amadori, D, Bruera, E. Guidelines on artificial nutrition versus hydration in terminal cancer patients. Nutrition 1996;12:163–7CrossRef Google Scholar PubMed

Fainsinger R. Hydration. In Gastrointestinal Symptoms in Advanced Cancer Patients, ed. C Ripamonti, E Bruera, pp. 395–410. Oxford: Oxford University Press, 2002

Fallon, M T. The physiology of somatostatin and its synthetic analogue, octreotide. Eur J Palliat Care 1994;1:20–2Google Scholar

Feuer, D J, Broadley, K E with members of the Systematic Review Steering Committee. Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancers. Ann Oncol 1999a;10:1035–41CrossRef Google Scholar

Feuer, D J, Broadley, K E, Shepherd, J H, Barton, D P J. Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. Gynecol Oncol 1999b;75:313–22CrossRef Google Scholar

Follon B G. Nausea and vomiting unrelated to cancer treatment. In Principles and Practice of Supportive Oncology, Vol. 12, ed. A Berger, R K Portenoy, D W Weissman, pp. 179–90. Philadelphia: Lippincott-Raven, 1998

MacDonald N. Ethical considerations in feeding or hydrating advanced cancer patients. In Gastrointestinal Symptoms in Advanced Cancer Patients, ed. C Ripamonti, E Bruera, pp. 411–23. Oxford: Oxford University Press, 2002

Mercadante, S. Pain in inoperable bowel obstruction. Pain Digest 1995;5:9–13Google Scholar

Pisters K M S, Kris M G. Treatment-related nausea and vomiting. In Principles and Practice of Supportive Oncology, Vol. 11, ed. A Berger, R K Portenoy, D W Weissman, pp. 165–77. Philadelphia: Lippincott-Raven, 1998

Ripamonti C. Bowel obstruction. In Principle and Practice of Supportive Oncology, ed. A Berger, R K Portenoy, D W Weissman, pp. 207–16. Philadelphia: Lippincott-Raven, 1998

Ripamonti C, Bruera E. Chronic nausea and vomiting. In Gastrointestinal Symptoms in Advanced Cancer Patients, ed. C Ripamonti, E Bruera, pp. 169–92. Oxford: Oxford University Press, 2002

Ripamonti, C, Twycross, R, Baines, M. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Working group of the European Association for Palliative Care. Support Care Cancer 2001;9:223–33CrossRef Google Scholar

Rousseau, P. Management of malignant bowel obstruction in advanced cancer: a brief review. J Palliat Med 1998;1:65–72CrossRef Google Scholar PubMed

Twycross, R, BackI, I,. Nausea and vomiting in advanced cancer. Eur J Palliat Care 1998;5:39–45Google Scholar

Ventafridda V, Ripamonti C, Sbanotto A, De Conno F. Mouth care. In Oxford Textbook of Palliative Medicine, ed. D Doyle, G W C Hanks, N MacDonald, pp. 691–707. Oxford: Oxford University Press, 1998